Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-76.93%
operating margin TTM
-65.09%
revenue TTM
83.97 Million
revenue per share TTM
1.59$
valuation ratios | |
|---|---|
| pe ratio | -8.39 |
| peg ratio | 0.18 |
| price to book ratio | 15.28 |
| price to sales ratio | 6.49 |
| enterprise value multiple | -9.74 |
| price fair value | 15.28 |
profitability ratios | |
|---|---|
| gross profit margin | 89.44% |
| operating profit margin | -65.09% |
| pretax profit margin | -73.83% |
| net profit margin | -76.93% |
| return on assets | -45.36% |
| return on equity | 26.28% |
| return on capital employed | -61.91% |
liquidity ratio | |
|---|---|
| current ratio | 2.48 |
| quick ratio | 2.12 |
| cash ratio | 0.40 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 795.05 |
| operating cycle | 878.53 |
| days of payables outstanding | 306.31 |
| cash conversion cycle | 572.22 |
| receivables turnover | 4.37 |
| payables turnover | 1.19 |
| inventory turnover | 0.46 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.45 |
| debt equity ratio | 1.80 |
| long term debt to capitalization | 0.57 |
| total debt to capitalization | 0.64 |
| interest coverage | -4.24 |
| cash flow to debt ratio | -0.85 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.72 |
| cash per share | 1.16 |
| operating cash flow per share | -0.72 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -0.85 |
| short term coverage ratios | -3.29 |
| capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
When was the last time G1 Therapeutics, Inc. (NASDAQ:GTHX) reported earnings?
G1 Therapeutics, Inc. (GTHX) published its most recent earnings results on 08-08-2024.
What is G1 Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. G1 Therapeutics, Inc. (NASDAQ:GTHX)'s trailing twelve months ROE is 26.28%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. G1 Therapeutics, Inc. (GTHX) currently has a ROA of -45.36%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did GTHX's net profit margin stand at?
GTHX reported a profit margin of -76.93% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is GTHX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.48 in the most recent quarter. The quick ratio stood at 2.12, with a Debt/Eq ratio of 1.80.